Registration of CARDIOVICE™ products to URPL (Office for Registration of Medicinal Products).

On May 24, 2021, the Company registered the CARDIOVICE products™ to the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products. This means that starting from 7 June this year, the Company may market its products. 

The following products were registered: 

  1. ECG signal recorder – CARDIOVICE ECG Recorder 
  1. Mobile applictaion – CARDIOVICE App (iOS, Android) 
  1. ECG vest – CARDIOVICE ECG Vest 
  1. ECG module – CARDIOVICE ECG Module